However, with the emergence of SMA animal models and a clearer appreciation of disease pathology in human patients, it has become apparent that reduced levels of SMN have additional effects on multiple other cell-types and tissues (7). The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.